Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AETHLON MEDICAL INCAEMD · Entity 8580 | Director | June 30, 2026 | July 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AETHLON MEDICAL INC
Report date June 30, 2026 · Filed July 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,840 |
Reported balance
After 2026-06-30 transaction · row 1
1 source rowRow 1 · 2026-06-30 · Tax withholding · Disposed 2,182 · Balance 20,840 F1: The Reporting Person forfeited 2,182 shares of common stock upon conversion of an aggregate 5,454 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 17, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person forfeited 2,182 shares of common stock upon conversion of an aggregate 5,454 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 17, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2026 Filed Jul 1, 2026 21:16 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 2,182 | $0.82 | $1,789.24 |
DisclosureSEC source: 0001683168-26-005226 · ownership.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,840 F1 · shares: The Reporting Person forfeited 2,182 shares of common stock upon conversion of an aggregate 5,454 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 17, 2026. Read SEC document |
| April 17, 2026 Filed Apr 21, 2026 21:00 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantCommon Stock | 21,815 | $2.29 | $49,956.35 |
DisclosureSEC source: 0001683168-26-003113 · ownership.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,021 F1 · shares: The Reporting Person was granted RSUs that vest in four equal quarterly installments on each of June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027, subject to the Reporting Person's continued service with the Company on each such vesting date. Read SEC document |
| March 31, 2026 Filed Apr 1, 2026 23:27 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 178 | $2.19 | $389.82 |
DisclosureSEC source: 0001683168-26-002589 · ownership.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,463 F1 · shares: The Reporting Person forfeited 178 shares of common stock upon conversion of an aggregate 268 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 25, 2025. Read SEC document |
| December 31, 2025 Filed Jan 2, 2026 23:43 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 179 | $2.77 | $495.83 |
DisclosureSEC source: 0001683168-26-000052 · ownership.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,356 F1 · shares: The Reporting Person forfeited 179 shares of common stock upon conversion of an aggregate 268 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 25, 2025. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:15 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 1,786 | $0.75 | $1,337.71 |
DisclosureSEC source: 0001683168-25-007377 · ownership.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,672 F1 · shares: The Reporting Person forfeited 1,786 shares of common stock upon conversion of an aggregate 4,465 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 25, 2025. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 20:03 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 1,786 | $1.20 | $2,143.20 |
DisclosureSEC source: 0001683168-25-004857 · ownership.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,993 F1 · shares: The Reporting Person forfeited 1,786 shares of common stock upon conversion of an aggregate 4,465 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 25, 2025. Read SEC document |
| April 23, 2025 Filed Apr 25, 2025 20:10 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantCommon Stock | 142,857 | $0.36 | $51,142.81 |
DisclosureSEC source: 0001683168-25-002835 · ownership.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,233 F1 · shares: The Reporting Person was granted RSUs that vest in four equal quarterly installments on each of June 30, 2025, September 30, 2025, December 31, 2025 and March 31, 2026, subject to the Reporting Person's continued service with the Company on each such vesting date. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 22:03 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 3,289 | $0.36 | $1,177.46 |
DisclosureSEC source: 0001683168-25-002186 · ownership.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,376 F1 · kind: The Reporting Person forfeited 3,289 shares of common stock upon conversion of an aggregate 8,224 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 17, 2023. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 22:15 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 3,289 | $0.86 | $2,828.54 |
DisclosureSEC source: 0001683168-25-000092 · ownership.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,665 F1 · kind: The Reporting Person forfeited 3,289 shares of common stock upon conversion of an aggregate 8,224 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 17, 2024. Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 21:30 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 3,289 | $0.47 | $1,532.67 |
DisclosureSEC source: 0001683168-24-006797 · ownership.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,954 F1 · kind: The Reporting Person forfeited 3,289 shares of common stock upon conversion of 8,224 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 17, 2024. Read SEC document |
| June 28, 2024 Filed Jul 1, 2024 20:15 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 3,289 | $0.50 | $1,641.21 |
DisclosureSEC source: 0001415889-24-018578 · form4-07012024_040707.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,243 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/16/24 Read SEC document |
| April 16, 2024 Filed Apr 17, 2024 20:57 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantCommon Stock | 32,894 | $1.52 | $49,998.88 |
DisclosureSEC source: 0001415889-24-011028 · form4-04172024_080423.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,532 F1 · shares: The RSU's vests in four equal quarterly installments on 6/30/24, 9/30/24, 12/31/24 and 3/31/25. Read SEC document |
| March 29, 2024 Filed Apr 1, 2024 21:05 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 1,163 | $1.68 | $1,953.84 |
DisclosureSEC source: 0001415889-24-009566 · form4-04012024_090418.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,638 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/28/23 Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 23:02 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 1,163 | $2.19 | $2,546.97 |
DisclosureSEC source: 0001209191-24-000220 · doc4.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,801 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/28/23 F2 · balance_after: The end of period holdings reflect a 1-10 reverse stock split effected by the Issuer on October 4, 2023. Read SEC document |
| September 29, 2023 Filed Sep 29, 2023 21:57 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 11,628 | $0.23 | $2,674.44 |
DisclosureSEC source: 0001209191-23-050880 · doc4.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,637 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/28/23 Read SEC document |
| June 30, 2023 Filed Jul 3, 2023 20:08 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 11,628 | $0.36 | $4,186.08 |
DisclosureSEC source: 0001209191-23-040547 · doc4.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,265 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/28/23 Read SEC document |
| April 28, 2023 Filed May 1, 2023 20:10 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantCommon Stock | 116,279 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-026257 · doc4.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,893 F1 · shares: The RSU's vests in four equal quarterly installments on 6/30/23, 9/30/23, 12/31/23 and 3/31/24. Read SEC document |
| March 31, 2023 Filed Mar 31, 2023 22:12 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 3,425 | $0.39 | $1,318.63 |
DisclosureSEC source: 0001209191-23-021935 · doc4.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,614 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/1/22 Read SEC document |
| December 30, 2022 Filed Dec 31, 2022 00:15 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 3,425 | $0.28 | $941.88 |
DisclosureSEC source: 0001209191-22-063050 · doc4.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,039 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/1/22 Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 15:33 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 6,849 | $0.58 | $3,986.12 |
DisclosureSEC source: 0001209191-22-052075 · doc4.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,464 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/1/22 Read SEC document |
| September 15, 2022 Filed Sep 16, 2022 15:08 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantCommon Stock | 34,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-050215 · doc4.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,313 F1 · shares: The RSU was granted on 4/1/22, but was contingent on stockholder approval of an increase in the shares issuable under the Issuer's 2020 Equity Incentive Plan at the Issuer's annual meeting of stockholders held on 9/15/22, and therefore for purposes of Section 16 the RSU was not "acquired" until such stockholder approval was obtained. 50% of the shares subject to the RSU will vest on 9/30/22, and 25% of the RSU's will vest on each of 12/31/22 and 3/31/23, subject to continuous service through each such date. Read SEC document |
| March 31, 2022 Filed Mar 31, 2022 22:47 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 2,430 | $1.46 | $3,547.80 |
DisclosureSEC source: 0001209191-22-021845 · doc4.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,066 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/1/21 Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 22:22 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 2,430 | $1.86 | $4,519.80 |
DisclosureSEC source: 0001209191-22-000268 · doc4.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,496 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/1/21 Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:38 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 2,430 | $3.86 | $9,379.80 |
DisclosureSEC source: 0001209191-21-058474 · doc4.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,926 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/1/21 Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 20:17 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 2,430 | $4.91 | $11,931.30 |
DisclosureSEC source: 0001209191-21-044376 · doc4.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,356 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/1/21 Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:38 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantCommon Stock | 24,295 | $2.06 | $50,047.70 |
DisclosureSEC source: 0001209191-21-024738 · doc4.xml · nonDerivative · entry 2 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,786 F2 · shares: The RSU's vests in four equal quarterly installments on 6/30/21, 9/30/21, 12/31/21 and 3/31/22. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:38 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 2,575 | $2.03 | $5,227.25 |
DisclosureSEC source: 0001209191-21-024738 · doc4.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,491 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/3/20 Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 21:07 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 2,575 | $2.47 | $6,360.25 |
DisclosureSEC source: 0001209191-21-000236 · doc4.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,066 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/3/20 Read SEC document |
| December 17, 2020 Filed Dec 18, 2020 22:00 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | SaleCommon Stock | 334 | $2.09 | $698.59 |
DisclosureSEC source: 0001209191-20-064458 · doc4.xml · nonDerivative · entry 3 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,641 Read SEC document |
| December 17, 2020 Filed Dec 18, 2020 22:00 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | SaleCommon Stock | 5,417 | $2.10 | $11,357.82 |
DisclosureSEC source: 0001209191-20-064458 · doc4.xml · nonDerivative · entry 2 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,975 Read SEC document |
| December 17, 2020 Filed Dec 18, 2020 22:00 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | SaleCommon Stock | 21,101 | $2.11 | $44,523.11 |
DisclosureSEC source: 0001209191-20-064458 · doc4.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,392 F1 · price: This transaction was executed in multiple trades at prices ranging from $2.09 to $2.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 30, 2020 Filed Oct 1, 2020 17:50 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 2,389 | $1.35 | $3,225.15 |
DisclosureSEC source: 0001209191-20-052566 · doc4.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,493 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/3/20 Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 18:45 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 2,389 | $2.03 | $4,849.67 |
DisclosureSEC source: 0001209191-20-040124 · doc4.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,953 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/3/20 Read SEC document |
| April 03, 2020 Filed Apr 7, 2020 19:20 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantCommon Stock | 23,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-023740 · doc4.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,342 F1 · shares: The RSU's vests in four equal quarterly installments on 6/30/2020, 9/30/2020, 12/31/2020 and 3/31/2021. Read SEC document |
| April 03, 2020 Filed Sep 17, 2020 17:07 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantCommon Stock | 929 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-050826 · doc4.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,882 F1 · shares: The RSU was granted on 4/3/20, but was contingent on stockholder approval of the Issuer's 2020 Equity Incentive Plan at the Issuer's annual meeting of stockholders held on 9/15/20, and therefore for purposes of Section 16, the RSU was not "acquired" until such stockholder approval was obtained. The RSU's vest in two equal installments on 12/31/2020 and 3/31/2021. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 19:22 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 244 | $1.52 | $370.88 |
DisclosureSEC source: 0001209191-20-022462 · doc4.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,449 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/1/19 Read SEC document |
| December 31, 2019 Filed Jan 2, 2020 23:46 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 246 | $0.84 | $207.60 |
DisclosureSEC source: 0001209191-20-000438 · doc4.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,693 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/1/19 F2 · balance_after: The end of period holdings reflect a 1-15 reverse stock split effected by the Issuer on October 14, 2019. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:50 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 3,684 | $0.24 | $865.74 |
DisclosureSEC source: 0001209191-19-051876 · doc4.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,075 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/1/19 Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 21:02 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 3,684 | $0.37 | $1,363.08 |
DisclosureSEC source: 0001209191-19-040397 · doc4.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,759 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU dated 4/1/19 F2 · balance_after: Includes RSU's that were originally reported in Table II of the Reporting Person's Form 4 filed 4/3/19. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 19:18 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantRestricted Stock Units (RSU) · Derivative | 36,842 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023051 · doc4.xml · derivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,842 Underlying: Common Stock · 36,842 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. F2 · derivative.exercise_date: The RSU's vests in four equal quarterly installments on 6/30/19, 9/30/19, 12/31/19 and 3/31/20. F2 · derivative.expiration_date: The RSU's vests in four equal quarterly installments on 6/30/19, 9/30/19, 12/31/19 and 3/31/20. Read SEC document |
| March 31, 2019 Filed May 15, 2019 16:12 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 3,573 | $0.95 | $3,394.35 |
DisclosureSEC source: 0001209191-19-029879 · doc5.xml · nonDerivative · entry 3 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,601 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU granted 6/14/18 Read SEC document |
| December 31, 2018 Filed May 15, 2019 16:12 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 3,573 | $1.30 | $4,644.90 |
DisclosureSEC source: 0001209191-19-029879 · doc5.xml · nonDerivative · entry 2 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,174 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU granted 6/14/18 Read SEC document |
| September 30, 2018 Filed May 15, 2019 16:12 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 3,573 | $1.18 | $4,216.14 |
DisclosureSEC source: 0001209191-19-029879 · doc5.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 336,747 F1 · acquired: Reporting the tax withholding of shares upon vesting of the RSU granted 6/14/18 Read SEC document |
| June 19, 2018 Filed Aug 1, 2018 01:16 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantRestricted Stock Units · Derivative | 26,799 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-18-002083 · ownership.xml · derivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,465 Underlying: Common Stock · 26,799 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: 37,234 restricted stock units vested ratably on 12/31/2017 and 3/31/2018. 26,799 restricted stock units to vest ratably on 9/30/18, 12/31/18 and 3/31/19. F2 · derivative.expiration_date: 37,234 restricted stock units vested ratably on 12/31/2017 and 3/31/2018. 26,799 restricted stock units to vest ratably on 9/30/18, 12/31/18 and 3/31/19. Read SEC document |
| June 14, 2018 Filed May 15, 2019 16:09 UTC Amendment | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantCommon Stock | 26,799 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-029877 · doc4a.xml · nonDerivative · entry 2 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,320 F1 · balance_after: Includes RSU's that were originally reported in Table II of the Reporting Person's prior Form 4 filings. Read SEC document |
| March 31, 2018 Filed May 15, 2019 16:09 UTC Amendment | AETHLON MEDICAL INC AEMD · Entity 8580 | Tax withholdingCommon Stock | 7,447 | $1.19 | $8,861.93 |
DisclosureSEC source: 0001209191-19-029877 · doc4a.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,521 F1 · balance_after: Includes RSU's that were originally reported in Table II of the Reporting Person's prior Form 4 filings. Read SEC document |
| November 27, 2017 Filed Dec 19, 2017 17:37 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GrantRestricted Stock Units · Derivative | 37,234 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-17-003346 · shah_f4.xml · derivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,666 Underlying: Common Stock · 37,234 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: Restricted stock units to vest ratably on 12/31/2017 and 3/31/2018. F2 · derivative.expiration_date: Restricted stock units to vest ratably on 12/31/2017 and 3/31/2018. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 23:30 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Exercise / conversionRestricted Stock Units · Derivative | 1,368 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-16-000249 · shah_fmr4-100416.xml · derivative · entry 2 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,736 Underlying: Common Stock · 1,368 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. For tax purposes, each share of common stock was valued at $4.99. F4 · derivative.exercise_date: 12,328 of the restricted stock units vested on the grant date, 8/9/16, and 1,368 of the remaining restricted stock units vested or will vest on each of 9/30/16, 12/31/16 and 3/31/17. F4 · derivative.expiration_date: 12,328 of the restricted stock units vested on the grant date, 8/9/16, and 1,368 of the remaining restricted stock units vested or will vest on each of 9/30/16, 12/31/16 and 3/31/17. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 23:30 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Exercise / conversionCommon Stock | 1,368 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-16-000249 · shah_fmr4-100416.xml · nonDerivative · entry 1 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,998 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the settlement in common stock of previously issued restricted stock units upon vesting of such units. F2 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. For tax purposes, each share of common stock was valued at $4.99. F3 · balance_after: In addition to the currently outstanding shares of common stock owned by the reporting person and reported here, the reporting person also beneficially owns the shares of common stock underlying the following stock options and warrants: options to purchase 7,520 shares of common stock at $4.10 per share, options to purchase 3,684 shares of common stock at $9.50 per share, and warrants to purchase 109,322 shares of common stock at exercise prices ranging from $4.65 per share to $6.60 per share. Read SEC document |
| September 01, 2016 Filed Sep 6, 2016 18:55 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Exercise / conversionRestricted Stock Units · Derivative | 12,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-16-000021 · shah_frm4.xml · derivative · entry 2 Shah Chetan · CIK 0001566040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,104 Underlying: Common Stock · 12,328 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. For tax purposes, each share of common stock was valued at $6.28, the closing price of the common stock on 8/9/16, the date of grant. F4 · derivative.exercise_date: 12,328 of the restricted stock units vested on the grant date, 8/9/16, and 1,368 of the remaining restricted stock units will vest on each of 9/30/16, 12/31/16 and 3/31/17. F4 · derivative.expiration_date: 12,328 of the restricted stock units vested on the grant date, 8/9/16, and 1,368 of the remaining restricted stock units will vest on each of 9/30/16, 12/31/16 and 3/31/17. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.